1.5300
-0.0400
(-2.55%)
At close: 4:00:00 PM EDT
1.5397
+0.01
+(0.63%)
After hours: 5:09:31 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-99,696
-99,696
-86,160
-57,000
-67,927
Investing Cash Flow
-129,555
-129,555
79,015
-184,689
32,534
Financing Cash Flow
226,084
226,084
691
219,012
1,202
End Cash Position
30,616
30,616
33,783
40,237
62,914
Capital Expenditure
-4,409
-4,409
-28,147
-47,111
-5,025
Issuance of Capital Stock
225,073
225,073
--
217,170
--
Free Cash Flow
-104,105
-104,105
-114,307
-104,111
-72,952
12/31/2021 - 7/10/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IPSC Century Therapeutics, Inc.
0.4078
-2.56%
ALXO ALX Oncology Holdings Inc.
0.4800
-7.46%
FATE Fate Therapeutics, Inc.
0.9352
+1.70%
CRBU Caribou Biosciences, Inc.
0.8595
-4.02%
LXEO Lexeo Therapeutics, Inc.
2.1700
-8.05%
GBIO Generation Bio Co.
0.3490
-6.31%
ARTV Artiva Biotherapeutics, Inc.
1.8400
-7.54%
KYTX Kyverna Therapeutics, Inc.
1.8700
-3.61%
SANA Sana Biotechnology, Inc.
1.5300
-1.29%
ALLO Allogene Therapeutics, Inc.
1.3700
-3.52%